Observational studyBMC infectious diseases2025
Outcomes of infective endocarditis in patients with end-stage renal disease in Spain: a population-based study.
Observational study in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Changing Patterns in Infective Endocarditis: A Contemporary Epidemiological Perspective.Pathogens (Basel, Switzerland) · 2026Review
- Diagnostic and Therapeutic Particularities of Sepsis in Hemodialysis Patients.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with end-stage renal disease (ESRD) have a higher risk of infective endocarditis (IE) and a worse prognosis associated with it. Our aim is to analyze the clinical characteristics and outcomes of patients with IE and ESRD in Spain, while exploring potential differences between patients undergoing dialysis and other patients with ESRD.
methodsRetrospective observational population-based study analyzing 9,008 episodes of IE recorded between 2016 and 2019, using data from the Spanish Minimum Basic DataSet. Among these, 428 patients had ESRD, including 332 who were undergoing dialysis. A multivariable and multilevel logistic regression model was constructed to assess the association between various factors and in-hospital mortality in ESRD patients.
resultsCompared to patients without ESRD, those with ESRD were younger, had more comorbidities, and showed a higher prevalence of infections caused by Staphylococcus aureus (31.8% vs. 18.4%; p < 0.001) and coagulase-negative staphylococci (19.2% vs. 14%; p = 0.006). ESRD patients also experienced septic shock more frequently as an in-hospital complication (12.1% vs. 8.9%; p = 0.007). Additionally, they underwent cardiac surgery less often (12.6% vs. 19.6%; p < 0.001) and had significantly higher in-hospital mortality rates (33.4% vs. 26.9%; p = 0.003) than patients without ESRD. Among ESRD patients, those undergoing dialysis had more comorbidities and a higher proportion of S. aureus infections (36.1% vs. 16.7%; p < 0.001). The multilevel analysis revealed that neither dialysis nor cardiac surgery were independently associated with in-hospital mortality.
conclusionsPatients with ESRD and IE exhibit distinct clinical and microbiological characteristics compared to other IE patients. Additionally, they are less likely to undergo cardiac surgery and experience significantly higher in-hospital mortality rates. In ESRD patients with IE, neither dialysis treatment nor cardiac surgery were identified as independent risk factors for mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.